Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Roche prepares new antiviral agents

March 18, 1997

Peptides for Japanese cedar allergies reported by Sankyo and Hayashibara

March 18, 1997

Antiatherosclerotic compounds described by Fuji Photo Film

March 18, 1997

Taisho claims orally active antiplatelet agents

March 18, 1997

Neuroprotective, analgesic and antitussive agents from Toray

March 18, 1997

Antihepatitis agents from Mitsubishi Chemical

March 18, 1997

Selective cGMP-PDE inhibitors claimed by Otsuka

March 14, 1997

Protein tyrosine kinase inhibitors from Glaxo Wellcome

March 14, 1997

Substance P antagonists described by Pfizer

March 14, 1997

Knoll claims two series of compounds for CNS disorders

March 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...